Literature DB >> 6606625

Induction of optimal mucosal antibody responses: effects of age, immunization route(s), and dosing schedule in rats.

N F Pierce.   

Abstract

The antitoxin response in intestinal mucosa was studied in rats immunized either intestinally or by combined parenteral and intestinal dosing with cholera toxin or cholera toxoid. Attention was given to the duration of enteric priming and the magnitude and time course of mucosal anti-cholera toxin responses in rats of defined age. Cholera toxin given only intraduodenally was a more efficient priming immunogen in young rats than in older rats and caused priming that lasted at least 32 weeks; repeated enteric doses increased local priming and repeatedly evoked vigorous mucosal anti-cholera toxin responses which occurred rapidly and declined slowly. Results differed when a portion of the immunizing regimen was parenteral. Cholera toxoid given intraperitoneally (i.p.) caused mucosal priming that peaked promptly and then rapidly declined; parenteral boosting after enteric priming was much more effective given i.p. than subcutaneously; moreover, the booster response was brief, virtually disappearing within 11 days, and could not be reproduced by a second i.p. immunization. These results accord with evidence that parenteral immunization both stimulates and suppresses mucosal secretory immunoglobulin A responses, whereas local immunization is not known to be suppressive. Evidence for parenterally induced suppression was the rapid decline in mucosal priming after i.p. immunization, the shortened mucosal antibody response after i.p. immunization, and possibly the inability to parenterally evoke a booster response twice. In these studies, the level of priming observed at different intervals after parenteral, enteric, or combined immunization appeared to reflect the sum of priming and suppressive effects evoked by the preceding immunization(s).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6606625      PMCID: PMC263432          DOI: 10.1128/iai.43.1.341-346.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Suppression of local intestinal immunoglobulin A immune response to cholera toxin by subcutaneous administration of cholera toxoids.

Authors:  S R Hamilton; J H Yardley; G D Brown
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

2.  Priming and suppression of the intestinal immune response to cholera toxoid/toxin by parenteral toxoid in rats.

Authors:  N F Pierce; F T Koster
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

3.  Intestinal immune response to cholera toxin: dependence on route and dosage of antigen for priming and boosting.

Authors:  A M Svennerholm; S Lange; J Holmgren
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

4.  Suppression of the intestinal immune response to cholera toxin by specific serum antibody.

Authors:  N F Pierce
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

5.  Protective antitoxic cholera immunity in mice: influence of route and number of immunizations and mode of action of protective antibodies.

Authors:  S Lange; J Holmgren
Journal:  Acta Pathol Microbiol Scand C       Date:  1978-08

6.  Parenteral immunization causes antigen-specific cell-mediated suppression of an intestinal IgA response.

Authors:  F T Koster; N F Pierce
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

7.  The role of antigen form and function in the primary and secondary intestinal immune responses to cholera toxin and toxoid in rats.

Authors:  N F Pierce
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

8.  The origin and antigen-dependent distribution of IgA-containing cells in the intestine.

Authors:  A J Husband; J L Gowans
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

9.  Differentiated B lymphocytes. Potential to express particular antibody variable and constant regions depends on site of lymphoid tissue and antigen load.

Authors:  P J Gearhart; J J Cebra
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

10.  Antibodies of the IgA type in intestinal plasma cells of germfree mice after oral or parenteral immunization with ferritin.

Authors:  P A Crabbé; D R Nash; H Bazin; D V Eyssen; J F Heremans
Journal:  J Exp Med       Date:  1969-10-01       Impact factor: 14.307

View more
  10 in total

1.  Local immune response and protection in the guinea pig keratoconjunctivitis model following immunization with Shigella vaccines.

Authors:  A B Hartman; L L Van de Verg; H H Collins; D B Tang; N O Bendiuk; D N Taylor; C J Powell
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

2.  Quantification of antigen-specific antibody-secreting cells in the small intestine and other lymphoid organs of mice after oral booster immunization.

Authors:  P J Van der Heijden; A T Bianchi; B A Bokhout; M Dol; J W Scholten; W Stok
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

3.  Immunization of rats with the 260-kilodalton Entamoeba histolytica galactose-inhibitable lectin elicits an intestinal secretory immunoglobulin A response that has in vitro adherence-inhibitory activity.

Authors:  B L Kelsall; J I Ravdin
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

4.  Deficient induction of the immune response to oral immunization with cholera toxin in malnourished rats during suckling.

Authors:  J Fló; M E Roux; E Massouh
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

5.  Contribution of immunoglobulin-secreting cells in the murine small intestine to the total 'background' immunoglobulin production.

Authors:  P J van der Heijden; W Stok; A T Bianchi
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

6.  Secretory immunoglobulin A response following peroral priming and challenge with Shigella flexneri lacking the 140-megadalton virulence plasmid.

Authors:  D F Keren; R A McDonald; S B Formal
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

7.  Combined parenteral and oral immunization results in an enhanced mucosal immunoglobulin A response to Shigella flexneri.

Authors:  D F Keren; R A McDonald; J L Carey
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

8.  Determinants of the immunogenicity of live virulent and mutant Vibrio cholerae O1 in rabbit intestine.

Authors:  N F Pierce; J B Kaper; J J Mekalanos; W C Cray; K Richardson
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

9.  Effect of parenteral immunization on the intestinal immune response to Salmonella typhi Ty21a.

Authors:  B D Forrest; J T LaBrooy; C E Dearlove; D J Shearman
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

10.  A recombinant immunotoxin targeting CD22 with low immunogenicity, low nonspecific toxicity, and high antitumor activity in mice.

Authors:  Johanna K Hansen; John E Weldon; Laiman Xiang; Richard Beers; Masanori Onda; Ira Pastan
Journal:  J Immunother       Date:  2010-04       Impact factor: 4.912

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.